Avastin vs Lucentis: Genentech Co-Pay Card Program Not Nearly Enough!
November 14, 2009
I received an e-mail this week from Genentech BioOncology, introducing their new Co-Pay Card Program. Genentech is the maker of the two drugs I have blogged about involved in the current macular degeneration treatment controversy, Lucentis and Acastin.
According to the e-mail:
“We are committed to ensuring that all eligible patients have access to the therapies they need. That is why we created the Genentech BioOncology Co-Pay Card Program, a program that gives eligible patients help with their BioOncology product co-pay.“
This program will basically pay the 20% co-pay for those patients that financially qualify. I think this is wonderful for certain treatment modalities, but not so in the case of Lucentis to treat macular degeneration. The co-pay would be around $400. What a nice gesture, what great marketing… In my opinion, this is a joke. What Genentech should be doing is seeking approval for the treatment of macular degeneration with Avastin! Then let the patient handle the $10 co-pay themselves!! Shame on you Genentech, hiding behind charity where corporate profits are the real issue!
Our world-class team of professionals at OCLI can help you with the latest treatment options for you.
Schedule an appointment
Are you a new patient? *
Start your search. Search by location or provider.
Please choose your preferred provider: *
Please complete the following to request your appointment:
Note: Self-scheduling is currently available for select locations. More locations will be available soon.
Loading...
Please complete the following to request your appointment:
Note: Self-scheduling is currently available for select locations. More locations will be available soon.
Loading...
Please complete the following to request your appointment:
Note: Self-scheduling is currently available for select locations. More locations will be available soon.
Loading...
Self-scheduling is not currently available for this provider, please complete form below and a member of the OCLI Vision team will contact you to schedule your appointment.
The practices of OCLI Vision offer eye care services at locations throughout Connecticut, New Jersey, New York, Pennsylvania and West Virginia and specialize in primary vision care, LASIK, cataract surgery, glaucoma, diabetic eye care, and other services for patients in the Northeast.
These locations include practice locations of OCLI Vision as well as the practice locations of other vision services providers and ambulatory surgery centers supported by the administrative services of Spectrum Vision Partners. Each location is identified by the vision service provider or company operating at the location.